These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 18619377

  • 21. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
    Adams HJ, Kwee TC.
    J Clin Oncol; 2015 Apr 01; 33(10):1217. PubMed ID: 25691675
    [No Abstract] [Full Text] [Related]

  • 22. Staging, response to therapy, and restaging of lymphomas with 18F-FDG PET.
    Altamirano J, Esparza JR, de la Garza Salazar J, Calvo PS, Vera SR, Chalapud Revelo JR, Estrada G.
    Arch Med Res; 2008 Jan 01; 39(1):69-77. PubMed ID: 18067998
    [Abstract] [Full Text] [Related]

  • 23. Positron emission tomography for detection and staging of malignant lymphoma.
    Buchmann I, Moog F, Schirrmeister H, Reske SN.
    Recent Results Cancer Res; 2000 Jan 01; 156():78-89. PubMed ID: 10802866
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
    Juweid ME.
    J Nucl Med; 2008 Jan 01; 49(1):9-12. PubMed ID: 18077522
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma.
    Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N, Coya J, Rodriguez-Vigil B, Madero R, Pinilla I, Martin-Curto LM.
    Br J Haematol; 2006 Nov 01; 135(3):293-302. PubMed ID: 17032175
    [Abstract] [Full Text] [Related]

  • 28. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
    Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.
    Cancer; 2002 Feb 15; 94(4):879-88. PubMed ID: 11920454
    [Abstract] [Full Text] [Related]

  • 29. Imaging for Staging and Response Assessment in Lymphoma.
    Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J.
    Radiology; 2015 Aug 15; 276(2):323-38. PubMed ID: 26203705
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
    Kostakoglu L.
    Clin Lymphoma Myeloma; 2008 Oct 15; 8(5):273-6. PubMed ID: 18854280
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D, de Wit M, Beyer W, Beese M, Lübeck M, Bücheler E, Clausen M.
    Rofo; 1998 May 15; 168(5):457-65. PubMed ID: 9617362
    [Abstract] [Full Text] [Related]

  • 34. [Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment].
    Mainolfi C, Maurea S, Varrella P, Alaia C, Imparato C, Alfano B, Abate G, Bazzicalupo L.
    Radiol Med; 1998 May 15; 95(1-2):98-104. PubMed ID: 9636735
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation.
    Svoboda J, Andreadis C, Elstrom R, Chong EA, Downs LH, Berkowitz A, Luger SM, Porter DL, Nasta S, Tsai D, Loren AW, Siegel DL, Glatstein E, Alavi A, Stadtmauer EA, Schuster SJ.
    Bone Marrow Transplant; 2006 Aug 15; 38(3):211-6. PubMed ID: 16770314
    [Abstract] [Full Text] [Related]

  • 38. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
    McCarten KM, Nadel HR, Shulkin BL, Cho SY.
    Pediatr Radiol; 2019 Oct 15; 49(11):1545-1564. PubMed ID: 31620854
    [Abstract] [Full Text] [Related]

  • 39. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
    Bourguet P, Groupe de Travail SOR.
    Bull Cancer; 2003 Feb 15; 90 Spec No():S88-95. PubMed ID: 12739340
    [No Abstract] [Full Text] [Related]

  • 40. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.
    Barrington SF, Kluge R.
    Eur J Nucl Med Mol Imaging; 2017 Aug 15; 44(Suppl 1):97-110. PubMed ID: 28411336
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.